RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Revenue

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥611.4B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
May 31, 20251,011,390+4.81%
May 31, 2024964,989+16.59%
May 31, 2023827,697+9.57%
May 31, 2022755,414+3.99%
May 31, 2021726,424+6.14%
May 31, 2020684,403+11.99%
May 31, 2019611,137+9.52%
May 31, 2018557,999+10.99%
May 31, 2017502,732+12.40%
May 31, 2016447,273+9.50%
May 31, 2015408,466+9.85%
May 31, 2014371,825+12.91%
May 31, 2013329,313+18.02%
May 31, 2012279,021+17.64%
May 31, 2011237,174

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)